desi-DMARC turns cryptic DMARC reports into clear answers: who's sending email as your domain, which mail is failing, and exactly how to lock spoofers out — step by safe step.
Request Early Access See How It Worksp=rejectNo jargon walls, no consultant lock-in. Just the tools to authenticate your email and keep it that way.
Point us at your domain and get a full SPF, DKIM, and DMARC health report in seconds — with plain-language fixes for every issue found.
We ingest your aggregate (RUA) reports and turn XML noise into dashboards: pass rates, failing sources, and alignment trends over time.
See every service sending as your domain — your mail provider, CRM, invoicing tool… and the impersonators who shouldn't be there.
Move from monitoring to quarantine to full reject with confidence-scored recommendations, so legitimate mail never breaks.
Get notified on new sending sources, sudden failure spikes, and record changes — not buried in noise.
DMARC protection shouldn't cost more than the domain it protects. Simple plans that small teams can actually afford.
From unprotected to enforced, in four steps.
Run a free health check on your SPF, DKIM, and DMARC records to see where you stand today.
Publish a DMARC record pointing reports to desi-DMARC. No mail flow changes, zero risk.
We analyze incoming reports, identify all your legitimate senders, and guide you through aligning them.
Flip to p=reject when it's safe. Spoofed mail gets blocked worldwide — and we keep watch.
Google, Yahoo, and Microsoft now require email authentication for bulk senders — and reject or junk mail that fails. Meanwhile, domain spoofing remains the launchpad for most phishing and invoice-fraud attacks.
Yet most domains — especially outside the Fortune 500 — still have no effective DMARC policy. Attackers know this. desi-DMARC exists to close that gap for everyone else: the startups, schools, agencies, and businesses the big vendors overlook.
desi-DMARC is launching soon. Join the early-access list and be first in line — early users get free domain monitoring during the beta.